Company Valuation: MEDICLIN AG

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 186.2 171 130.2 115 175.8 242.2 - -
Change - -8.16% -23.89% -11.68% 52.89% 37.84% - -
Enterprise Value (EV) 186.2 171 130.2 115 175.8 242.2 242.2 242.2
Change - -8.16% -23.89% -11.68% 52.89% 37.84% 0% 0%
P/E - - - - - - - -
PBR 1.02x 0.82x 0.66x 0.52x 0.71x 0.85x 0.76x 0.67x
PEG - - - - - - - -
Capitalization / Revenue 0.28x 0.24x 0.18x 0.15x 0.22x 0.31x 0.3x 0.3x
EV / Revenue 0x 0x 0x 0x 0x 0.31x 0.3x 0.3x
EV / EBITDA 0x 0x 0x 0x 0x 2.12x 2.1x 2.1x
EV / EBIT 0x 0x 0x 0x 0x 3.9x 3.88x 3.86x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 - - - - 0.04 0.04 0.04 0.04
Rate of return - - - - 1.08% 0.78% 0.78% 0.78%
EPS 2 - - - - - - - -
Distribution rate - - - - - - - -
Net sales 1 673.1 704.7 730.1 748.8 784.5 787.5 803.2 819.3
EBITDA 1 85.22 90.92 98.73 103.8 115.6 114.3 115.3 115.6
EBIT 1 11.56 19.52 12.72 53.49 55.36 62.11 62.47 62.72
Net income 1 1.461 9.441 -10.78 24.84 25.49 36.66 38.2 40.12
Net Debt - - - - - - - -
Reference price 2 3.920 3.600 2.740 2.420 3.700 5.100 5.100 5.100
Nbr of stocks (in thousands) 47,500 47,500 47,500 47,500 47,500 47,500 - -
Announcement Date 30/03/22 31/03/23 27/03/24 28/03/25 27/03/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
12.58x0.39x8.14x3.08% 111B
14.42x1.81x9.05x0.73% 92.38B
-290x19.96x-345.46x-.--% 59.15B
13.32x1.47x8.86x2.68% 27.66B
22.96x2.57x13x1.42% 25.75B
22.14x2.05x11.72x0.94% 25.02B
30.99x5.59x23.23x2.25% 20.99B
7.85x1.42x6.45x-.--% 20.82B
30.49x2.86x12.85x1.47% 16.87B
Average -15.03x 4.23x -28.02x 1.4% 44.36B
Weighted average by Cap. -29.03x 4.37x -42.55x 1.54%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield